Riverhead Capital

Riverhead Capital, established in January 2015, operates as the private equity division of Sunshine Insurance Group in Beijing, China. As one of the initial insurance private fund pilot units sanctioned by the China Insurance Regulatory Commission, it manages assets totaling 17 billion yuan. The firm focuses on investments across various sectors, including healthcare, emerging industries, industrial mergers and acquisitions, and real estate. Its approach encompasses a range of strategies such as entrepreneurial support, strategic and financial investments, mergers and acquisitions, corporate restructuring, and cross-border investments. Riverhead Capital aims to enhance corporate value and promote the sustainable development of businesses, having already invested in multiple companies within medical, pharmaceutical, internet, and innovative financial services sectors.

Shenghao Shi

Managing Partner

31 past transactions

Hisky Medical

Series D in 2025
Hisky Medical is a company based in Beijing, China, established in 2010, that specializes in the development, manufacturing, and marketing of medical equipment aimed at non-invasive liver diagnosis. The firm focuses on innovative technologies for disease diagnosis and has developed a product called FibroTouch, which is designed to facilitate the assessment of liver conditions without the need for invasive procedures. Through its advancements in medical technology, Hisky Medical aims to improve diagnostic accuracy and patient comfort in the evaluation of liver health.

Nanos Medical

Venture Round in 2025
Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily targeting the cardiovascular and ear, nose, and throat (ENT) fields. The company offers a range of innovative products, including sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and drug-eluting stents for sinus applications. Through its advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and patients, contributing to improved healthcare outcomes.

Unisic Technology

Series B in 2024
Unisic specializes in the design and manufacturing of silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including power modules and driver circuits. Unisic's technology finds applications across various sectors, such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By focusing on customized application solutions, Unisic aims to enhance the performance and efficiency of power systems in these critical fields.

AaltoSemi

Private Equity Round in 2024
AaltoSemi specializes in providing comprehensive integrated circuit (IC) substrate services, encompassing research and development, design, production, and testing. The company offers a range of substrate products, including Coreless, ETS, FCCSP, and FCBGA substrates, tailored for advanced applications in the semiconductor industry. These substrates are critical for facilitating communication between chips and circuit boards, particularly in the context of increasingly complex chip designs and the growing demand for chips in automotive electronics. AaltoSemi focuses on achieving high precision, quality, and reliability in its mass production processes, supporting the development of essential technologies such as CPUs, GPUs, FPGAs, network ASICs, and 5G mobile devices.

Ningkang Ruizhu

Series A in 2023
Rezubio Pharmaceuticals is a biotech company that focuses on technologies to deliver drugs to diseased tissues or organs, maximizing the desired efficacies while minimizing the adverse effects. They concentrate on oncology, metabolic disease, and immunology as specific disease areas.

Medical Source

Series B in 2023
Yiyuan Medical Technology is a high-tech enterprise specializing in the research and development, production, sales, technical services and technical consultation of medical CT tubes.

Bio-Engine

Series C in 2023
Bio-Engine specializes in the research and development of veterinary biological products, focusing on the creation and manufacturing of antibodies, recombinant proteins, and vaccines for both human and livestock viruses. The company utilizes high-density serum-free suspension culture technology for animal cells, which enhances the efficiency of its products. Key offerings include serum-free media for various cell types, such as HEK293 and PK15, applicable in fields like cell therapy and vaccine production. In addition to product development, Bio-Engine provides clinical trial services to pharmaceutical manufacturers and scientific research organizations. Founded in 2014 and headquartered in Shanghai, China, the company is committed to advancing biotechnological solutions in the veterinary sector.

D2M Biotherapeutics

Series A in 2023
D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.

Sijie Microelectronics

Series C in 2023
Sijie Microelectronics produces sensors and internet-of-things technology. Their product applications include car radar, security systems, smart bathrooms, smart transportation, level measurement, parking detection, smart IoT, smart appliances, and more.

Huzhou Shenke

Series B in 2023
Huzhou Shenke specializes in the research and development of key technologies and products in the biological sector. The company focuses on analytical technologies and detection tools, offering a range of products such as fluorescent quantitative Polymerase Chain Reaction (PCR) instruments, digital PCR instruments, protein purification systems, and standardized detection kits for host cell nucleic acids. These offerings aim to provide accurate detection and analysis of nucleic acids, proteins, cells, and viruses, ensuring the availability of safe and reliable medical products. Through its innovative solutions, Huzhou Shenke contributes to advancements in the field of biological products and detection services.

Cell Probio

Series B in 2022
Cell Probio is a manufacturer of cell culture consumables, positioned in the R&D, production and sales of high-end biological consumables.

WuXi Bo Rui Biotechnology

Series A in 2022
WuXi Bo Rui Biotechnology develops a radioactive molecular imaging and nuclear drug transformation platform for the precise diagnosis and treatment of tumors. WuXi Bo Rui Biotechnology focuses on the transformation and development of new radionuclide drugs, covering multiple fields of small molecules, peptides, and antibodies, for the diagnosis and treatment of tumors, using their professional platform for targeted precursor design, screening, and radionuclide labeling. While increasing the efficiency of research and development, it also fully utilizes the benefits of accurate nuclear medicine diagnosis and treatment

Yingsheng Biology

Series B in 2020
Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development and production of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, and metabolic disorders. The company offers a diverse range of products, including 45 innovative genetic metabolic disease screening reagents, deaf genetic testing kits, and HLA-B27 detection kits. These products aim to facilitate early detection of genetic conditions and birth defects, promoting timely intervention and disease prevention. Yingsheng Bio utilizes advanced molecular diagnostic techniques and sophisticated detection systems, contributing significantly to the fields of human genetics and public health.

Sirnaomics

Series D in 2020
Sirnaomics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapeutics for significant human diseases using RNA interference (RNAi) technology. Founded in 2007 and headquartered in Gaithersburg, Maryland, with additional offices in Cambridge, Massachusetts, and facilities in Suzhou and Guangzhou, China, Sirnaomics is dedicated to addressing critical medical needs in oncology, anti-fibrotic therapeutics, and viral infections. The company's product portfolio includes several small interfering RNA (siRNA) therapeutics such as STP705 for scar reduction, STP909 for colon cancer, and STP900 for HPV and cervical cancer, among others. Sirnaomics employs proprietary Polypeptide Nano-Particle (PNP) technology to enhance drug delivery, allowing effective targeting of the tumor microenvironment and various cell types, particularly in the liver. Through its innovative approach, Sirnaomics aims to create impactful treatments for diseases with large market opportunities.

Lepu Bio

Series B in 2020
Lepu Biotechnology Co., Ltd. is a Chinese biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform dedicated to target discovery, drug preparation, development, and manufacturing. The company focuses on creating drug candidates that include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). Lepu Bio's core products are currently in clinical stages I to III, demonstrating its commitment to advancing cancer treatment through innovative biopharmaceutical solutions.

Ruipeng Pet Healthcare

Venture Round in 2020
Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator, which covers pet healthcare, foster care, bathing, SPA, beauty, food, entertainment and leisure services.

AW Education International

Series B in 2020
AW Education International is an overseas education consulting firm that specializes in providing study abroad services for high school, university, and Master's students in China. The company offers a comprehensive range of services designed to assist students in applying to study in North America, Europe, Australia, and Asia. These services include preparation for English proficiency and university entrance exams, as well as access to internship and volunteer opportunities that enhance students' resumes. By serving as a one-stop service platform, AW Education International aims to support families in navigating the complexities of international education.

Eswin

Series B in 2020
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.

Sunny Dental

Series A in 2020
Sunny Dental, founded in 2007 and based in Beijing, China, specializes in a wide range of orthodontic and dental services. The company provides diagnosis and treatment for dental implants, children's dentistry, dental restorations, periodontal disease, and dental pulp issues. Additionally, it offers oral and maxillofacial surgery as well as invasive extraction services. Sunny Dental aims to deliver professional care in all aspects of dental health, catering to various patient needs.

Chao Ju Ophthalmology

Series C in 2019
Chao Ju Ophthalmology Hospital, established in 1988 and based in China, specializes in ophthalmic treatments, particularly laser and refractive eye surgeries. With over 30 years of experience in the field, the institution has developed a strong technical foundation, employing more than 2,000 professionals, including professors, researchers, and senior physicians. Additionally, the hospital operates over 100 medical clinics staffed by clinical professors, allowing it to provide comprehensive eye care services.

Enflame Technology

Series A in 2019
Enflame, also known as Suiyuan Technology, specializes in developing advanced neural network solutions for artificial intelligence applications. The company focuses on creating high-end deep learning chips designed specifically for cloud data centers, optimizing them for AI training platforms. These chips feature a proprietary architecture that delivers significant computational power while ensuring high energy efficiency and low costs. Additionally, they are programmable and compatible with mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Rundo Medical

Series C in 2019
Rundong Pharmaceutical R&D is a contract research organization (CRO) that focuses on clinical research outsourcing for pharmaceutical and biotechnology companies. It offers a comprehensive range of services, including clinical operations, medical data management, biostatistics, and medical project management. As a key player in the industry, Rundong is the main initiator and promoter of the China CRO Alliance, highlighting its leadership role in the field. The company has also achieved the distinction of being the first CRO in China to receive ISO 9001:2008 quality management system certification, demonstrating its commitment to high-quality standards in clinical research. Through its professional services, Rundong aims to support various companies in the pharmaceutical and biotech sectors in advancing their medical research initiatives.

Lionbridge Financing Leasing

Corporate Round in 2018
Lionbridge is a commercial vehicle smart finance and service platform that creatively combines financial capital and industrial operation. It specializes in services for industries such as logistics transportation, auto finance, health care, new energy & new equipment, etc. The company is committed to the concept of connecting symbiosis and uses technology tools and financial instruments to empower partners to develop new operating models and gain greater value. Lionbridge was founded in 2012 and is based in Beijing, China. In September 2014, the company was acquired by [Bain Capital](/organization/bain-capital-2), a US-based private equity firm.

Meilianzhonghe Veterinary Hospital

Series A in 2017
Meilianzhonghe Veterinary Hospital offers pet diagnosis and treatment services. It offers services to the pet medical industry. The company's services include pet grooming, pet care, and pet training.

Ruipeng Pet Healthcare

Corporate Round in 2017
Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator, which covers pet healthcare, foster care, bathing, SPA, beauty, food, entertainment and leisure services.

QingCloud

Series D in 2017
QingCloud is a cloud computing platform based in China that specializes in Infrastructure as a Service (IaaS). The company offers a range of flexible cloud services, including support for private networks, hourly billing, open APIs, comprehensive monitoring, and multiple real-time data security policies. Founded by former professionals from Tencent, Baidu, and IBM, QingCloud aims to create a highly optimized IaaS platform inspired by the model of major industry players. Richard, the company's CEO, has emphasized QingCloud's ambition to evolve into a globally recognized cloud platform. The company plans to initiate expansion efforts in the Asia Pacific region, aiming to broaden its international presence and enhance its service offerings to meet the demands of the digital landscape.

Miao

Series A in 2016
MORE Health’s is a heath startup that aims to offer access to the best physicians in the world when they are needed the most; when patients are faced with a critical, potentially life-changing illness, such as cancer or heart disease. More health started as an incubation project under Chinese conglomerate SanPower Group.

Yangguang Huxin

Angel Round in 2016
Yangguang Huxin provides financial service and consumer installment services.

Yingyuqu Peiyin

Seed Round in 2016
Hangzhou Feizhu Technology is an English learning platform that conducts research and develops oral English education products. They provide dubbing practice, enabling English learners to improve their spoken English. They change the future of the online education industry by integrating social resources with the mobile Internet and providing English learners with an interesting, trendy, and scientific learning platform.

You Liang Sheng Huo

Angel Round in 2015
You Liang Sheng Huo is a food delivery company that specializes in catering services for enterprises. The business focuses on the centralized collection and purchasing of ingredients, ensuring strict control over their origin and quality. This approach allows You Liang Sheng Huo to provide high-quality meals with consistent taste, which in turn fosters strong customer loyalty and generates repeat orders.

Mass Medical International

Angel Round in 2015
Mass Medical International is a provider of comprehensive medical services aimed at facilitating access to healthcare resources for its clients. The company operates an online platform that connects Chinese customers with international medical treatment options, including expert consultations, overseas treatments, high-end physical examinations, and precision medicine. Additionally, Mass Medical International offers training programs focused on hospital management and clinical skills, as well as opportunities for laboratory research visits and hospital observation. The firm also specializes in the development of hospital disciplines and provides management consulting services, ensuring that clients receive effective and high-quality medical care. Through its diverse offerings, Mass Medical International aims to simplify the process of accessing advanced healthcare solutions for its customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.